✦ LIBER ✦

Pegylated (40 KDA) interferon alfa-2a (PEGASYS®) in new combination therapies: a report of a randomized, multicenter efficacy and safety study

✍ Scribed by A.M. Di Bisceglie; D.E. Bernstein; V.R. Rustgi; N. Gitlin; L.J. Jeffers; D. Simon; J. Campagna; S.C. Pappas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated (40kDa) interferon alfa-2a (PE

✍ Michael W. Fried; Mitchell L. Shiffman; Rejender K. Reddy; Coleman Smith; George 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Pegylated (40 kDa) interferon alfa-2a (P

✍ Herrine, Steven K.; Brown, Robert; Esposito, Stephen; Lok, Anna; Galati, Joseph 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Pegylated (40 kDa) interferon alfa-2a (P

✍ Afdhal, Nezam; Flamm, Steven; Imperial, Joanne; Malet, Peter F.; Tong, Myron; Ca 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Efficacy and safety of interferon alfa-2

✍ Petr Husa; Vladislav Krtek; Jiri Svejda; Jaroslav Stransky; Blanka Cieslarova; V 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Efficacy and Safety of Pegylated Interfe

✍ Tseng, Po-Lin; Chen, Te-Chuan; Chien, Yu-Shu; Hung, Chao-Hung; Yen, Yi-Hao; Chan 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 384 KB

Evaluation of the safety and efficacy of

✍ S. Zeuzem; S.V. Feinman; J. Rasenack; E.J. Heathcote; M.-Y. Lai; E. Gane; J. O'G 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 166 KB